Article Versions Notes

Terpos E, Liontos M, Fiste O, Zagouri F, Briasoulis A, Sklirou AD, Markellos C, Skafida E, Papatheodoridi A, Andrikopoulou A, et al. SARS-CoV-2 Neutralizing Antibodies Kinetics Postvaccination in Cancer Patients under Treatment with Immune Checkpoint Inhibition. Cancers. 2022; 14(11):2796. https://doi.org/10.3390/cancers14112796

Terpos, Evangelos, Michalis Liontos, Oraianthi Fiste, Flora Zagouri, Alexandros Briasoulis, Aimilia D. Sklirou, Christos Markellos, Efthymia Skafida, Alkistis Papatheodoridi, Angeliki Andrikopoulou, and et al. 2022. "SARS-CoV-2 Neutralizing Antibodies Kinetics Postvaccination in Cancer Patients under Treatment with Immune Checkpoint Inhibition" Cancers 14, no. 11: 2796. https://doi.org/10.3390/cancers14112796

Terpos, E., Liontos, M., Fiste, O., Zagouri, F., Briasoulis, A., Sklirou, A. D., Markellos, C., Skafida, E., Papatheodoridi, A., Andrikopoulou, A., Koutsoukos, K., Kaparelou, M., Iconomidou, V. A., Trougakos, I. P., & Dimopoulos, M. -A. (2022). SARS-CoV-2 Neutralizing Antibodies Kinetics Postvaccination in Cancer Patients under Treatment with Immune Checkpoint Inhibition. Cancers, 14(11), 2796. https://doi.org/10.3390/cancers14112796